Tag Archives: The Stem Cell Blog

French Biotech gets an EU CRISPR Patent for CAR-T Research – Labiotech.eu (blog)

Labiotech.eu (blog)French Biotech gets an EU CRISPR Patent for CAR-T ResearchLabiotech.eu (blog)The new European patent granted to Cellectis covers the use of RNA-guided endonucleases in primary T cells, which includes both the Cas9 and Cpf1 versions o… Continue reading

French Biotech gets an EU CRISPR Patent for CAR-T Research – Labiotech.eu (blog)

French Biotech gets an EU CRISPR Patent for CAR-T ResearchLabiotech.eu (blog)The new European patent granted to Cellectis covers the use of RNA-guided endonucleases in primary T cells, which includes both the Cas9 and Cpf1 versions of CRISPR. The paten… Continue reading

Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Usual Trading Volume – First News 24

Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Usual Trading VolumeFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotell… Continue reading

Lilly, Nektar to co-develop new immunotherapy – PharmaTimes

Breakthrough in Advanced Kidney Disease by Stem Cell Genetic Med – Markets Insider

Markets InsiderBreakthrough in Advanced Kidney Disease by Stem Cell Genetic MedMarkets InsiderNevertheless, he felt the need to search the internet for other possible solutions. It was Stem Cell Genetic Med that caught his interest. After careful detai… Continue reading

Health Shorts: Stem cell ‘cures,’ Sugar spike, Longevity – Sarasota Herald-Tribune

BRIEF-Cellectis is granted patent for CRISPR use in T-cells – Reuters

BRIEF-Cellectis is granted patent for CRISPR use in T-cellsReutersANNOUNCED ON MONDAY ABOUT THE GRANT BY THE EUROPEAN PATENT OFFICE OF PATENT NO. EP3004337 FOR THE INVENTION OF USING RNA-GUIDED ENDONUCLEASES, SUCH AS CAS9 OR CPF1 FOR THE GENETIC … Continue reading